TIMP1 and ovarian carcinoma: In a study in 37 patients aged 29 to 78 years with epithelial ovarian cancer at the FIGO I (1 case), FIGO II (1 case), FIGO III (29 cases) and FIGO IV (6 cases) stages, concentrations of TIMP-1 in blood serum were determined [32].